RU-58841
Cas No: 154992-24-2
MF: C17H18F3N3O3
MW: 369.34
Assay:98%
Appearance: white powder
Applications:
RU-58841 strongly inhibits the transcription of PPAR&alpha and the coactivation of PPAR&alpha. In adipocyte studies it has been shown to antagonize lipolysis induced by isoprenaline and has been suggested for use in kinase cascade research. Additionally, research indicates that RU-58841 blocks the differentiation of 3T3-L1 (sc-2243) adipocytes.
RU-58841 has been used clinically to treat and protect against cardiac ischemic injury.
Specifications: COA
Tests |
Specifications |
Results |
Appearance |
White powder |
Off-White powder |
HNMR |
Conforms to structure |
conforms |
LCMS |
Conforms to MW |
conforms |
Assay |
≧98.0% |
99.3% |
Conclusion |
Complies with enterprise standard |